MA-2

MARKET APPROVAL OF THE YEAR


This award recognises a European life science company that through excellence in strategy, process, patient focus and negotiation was able to successfully gain the market approval of a transformational new therapy, drug, diagnostic tool, digital application or medical device. 

Qualifying criteria

- Open to all biotech, medtech, healthtech, pharma / Commercial leaders with European Headquarters
- Market approval to have been achieved in the period between 1 September 2018 and 1 September 2019

Judges will be paying particular attention to:

- Targeting of unmet medical need / improvement on existing on-market drugs
- Market potential / size
- Speed / progress through late-stage clinical / development stages
- Key indicators / results / inflection points of development
- Outline of future timelines / value creation
 
 
SUBMIT YOUR NOMINATION
 

BUY TICKETS AND TABLES